Phenprocoumon
- Generic Name
- Phenprocoumon
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H16O3
- CAS Number
- 435-97-2
- Unique Ingredient Identifier
- Q08SIO485D
- Background
Coumarin derivative that acts as a long-acting oral anticoagulant.
- Indication
Used for the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).
- Associated Conditions
- Myocardial Infarction, Thrombosis, Venous Embolism
- Associated Therapies
- -
Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-01-04
- Last Posted Date
- 2012-04-02
- Lead Sponsor
- Cantonal Hospital of St. Gallen
- Target Recruit Count
- 302
- Registration Number
- NCT00586287
- Locations
- 🇨ðŸ‡
Cantonal Hospital St. Gallen, St. Gallen, Switzerland
Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications
- First Posted Date
- 2007-09-12
- Last Posted Date
- 2013-12-11
- Lead Sponsor
- Heart and Diabetes Center North-Rhine Westfalia
- Target Recruit Count
- 1571
- Registration Number
- NCT00528671
- Locations
- 🇩🇪
Heart and Diabetes Center NRW, Bad Oeynhausen, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath